{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:20:19Z","timestamp":1793388019481,"version":"4.5.0"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T00:00:00Z","timestamp":1373414400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Imaging"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s40336-013-0026-y","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T06:09:26Z","timestamp":1373350166000},"page":"217-233","source":"Crossref","is-referenced-by-count":278,"title":["Glucose metabolism in normal aging and Alzheimer\u2019s disease: methodological and physiological considerations for PET studies"],"prefix":"10.1007","volume":"1","author":[{"given":"Lisa","family":"Mosconi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,10]]},"reference":[{"key":"26_CR1","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/archneur.59.11.1737","volume":"59","author":"WA Kukull","year":"2002","unstructured":"Kukull WA, Higdon R, Bowen JD et al (2002) Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol 59:1737\u20131746","journal-title":"Arch Neurol"},{"key":"26_CR2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"26_CR3","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1212\/WNL.52.6.1158","volume":"52","author":"A Delacourte","year":"1999","unstructured":"Delacourte A, David JP, Sergeant N et al (1999) The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer\u2019s disease. Neurology 52:1158\u20131165","journal-title":"Neurology"},{"key":"26_CR4","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archneur.58.9.1395","volume":"58","author":"JL Price","year":"2001","unstructured":"Price JL, Ko AI, Wade MJ, Tsou SK, McKeel DW, Morris JC (2001) Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch Neurol 58:1395\u20131402","journal-title":"Arch Neurol"},{"key":"26_CR5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide. Nat Rev Mol Cell Biol 8:101\u2013112","journal-title":"Nat Rev Mol Cell Biol"},{"key":"26_CR6","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1523\/JNEUROSCI.21-12-04183.2001","volume":"21","author":"D Pratico","year":"2001","unstructured":"Pratico D, Uryu K, Leight S, Trojanoswki JQ, Lee VM (2001) Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 21:4183\u20134187","journal-title":"J Neurosci"},{"key":"26_CR7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(01)00476-7","volume":"32","author":"RE Tanzi","year":"2001","unstructured":"Tanzi RE, Bertram L (2001) New frontiers in Alzheimer\u2019s disease genetics. Neuron 32:181\u2013184","journal-title":"Neuron"},{"key":"26_CR8","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe DJ (2002) Alzheimer\u2019s disease is a synaptic failure. Science 298:789\u2013791","journal-title":"Science"},{"key":"26_CR9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.275.5300.630","volume":"275","author":"DJ Selkoe","year":"1997","unstructured":"Selkoe DJ (1997) Alzheimer\u2019s disease: genotypes, phenotypes, and treatments. Science 275:630\u2013631","journal-title":"Science"},{"key":"26_CR10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","volume":"6","author":"K Blennow","year":"2010","unstructured":"Blennow K, Hampel H, Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol. 6:131\u2013144","journal-title":"Nat Rev Neurol."},{"issue":"Suppl 2","key":"26_CR11","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.3233\/JAD-2010-100339","volume":"20","author":"RH Swerdlow","year":"2010","unstructured":"Swerdlow RH, Burns JM, Khan SM (2010) The Alzheimer\u2019s disease mitochondrial cascade hypothesis. J Alzheimers Dis 20(Suppl 2):S265\u2013S279","journal-title":"J Alzheimers Dis"},{"key":"26_CR12","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1089\/ars.2011.4149","volume":"16","author":"RH Swerdlow","year":"2012","unstructured":"Swerdlow RH (2012) Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer\u2019s disease. Antioxid Redox Signal 16:1434\u20131455","journal-title":"Antioxid Redox Signal"},{"key":"26_CR13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrn1886","volume":"7","author":"MP Mattson","year":"2006","unstructured":"Mattson MP, Magnus T (2006) Ageing and neuronal vulnerability. Nat Rev Neurosci 7:278\u2013294","journal-title":"Nat Rev Neurosci"},{"key":"26_CR14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787\u2013795","journal-title":"Nature"},{"key":"26_CR15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ana.410380304","volume":"38","author":"MF Beal","year":"1995","unstructured":"Beal MF (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol. 38:357\u2013366","journal-title":"Ann Neurol."},{"key":"26_CR16","doi-asserted-by":"crossref","first-page":"7915","DOI":"10.1073\/pnas.90.17.7915","volume":"90","author":"BN Ames","year":"1993","unstructured":"Ames BN, Shigenaga MK, Hagen TM (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 90:7915\u20137922","journal-title":"Proc Natl Acad Sci USA"},{"key":"26_CR17","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD, Masliah E, Salmon DP et al (1991) Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572\u2013580","journal-title":"Ann Neurol"},{"key":"26_CR18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1126\/science.278.5337.412","volume":"278","author":"JH Morrison","year":"1997","unstructured":"Morrison JH, Hof PR (1997) Life and death of neurons in the aging brain. Science 278:412\u2013419","journal-title":"Science"},{"key":"26_CR19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3940(96)12668-9","volume":"210","author":"H Braak","year":"1996","unstructured":"Braak H, Braak E, Bohl J, Reintjes R (1996) Age, neurofibrillary changes, A beta-amyloid and the onset of Alzheimer\u2019s disease. Neurosci Lett 210:87\u201390","journal-title":"Neurosci Lett"},{"key":"26_CR20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1471-4159.1977.tb03919.x","volume":"29","author":"L Sokoloff","year":"1977","unstructured":"Sokoloff L (1977) Relation between physiological function and energy metabolism in the central nervous system. J Neurochem 29:13\u201326","journal-title":"J Neurochem"},{"key":"26_CR21","unstructured":"Clarke DD, Sokoloff L (1994) Circulation and energy metabolism of the brain. In: Siegel GJ, Agranoff BW, Albers RW, Molinoff PB (eds) Basic Neurochemistry. Raven Press, New York, pp 645\u2013680"},{"key":"26_CR22","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0140-6736(09)60697-8","volume":"373","author":"KK Ray","year":"2009","unstructured":"Ray KK, Seshasai SR, Wijesuriya S et al (2009) Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 373:1765\u20131772","journal-title":"Lancet"},{"key":"26_CR23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0166-2236(89)90165-3","volume":"12","author":"MT Wong-Riley","year":"1989","unstructured":"Wong-Riley MT (1989) Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci 12:94\u2013101","journal-title":"Trends Neurosci"},{"key":"26_CR24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00005072-196507000-00008","volume":"24","author":"RI Friede","year":"1965","unstructured":"Friede RI (1965) Enzyme histochemical studies of senile plaques. J Neuropathol Exp Neurol 24:477\u2013491","journal-title":"J Neuropathol Exp Neurol"},{"key":"26_CR25","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/ana.410360510","volume":"36","author":"P Mecocci","year":"1994","unstructured":"Mecocci P, MacGarvey U, Beal MF (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer\u2019s disease. Ann Neurol. 36:747\u2013751","journal-title":"Ann Neurol."},{"key":"26_CR26","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1471-4159.1990.tb08858.x","volume":"55","author":"KV Subbarao","year":"1990","unstructured":"Subbarao KV, Richardson JS, Ang LC (1990) Autopsy samples of Alzheimer\u2019s cortex show increased peroxidation in vitro. J Neurochem 55:342\u2013345","journal-title":"J Neurochem"},{"key":"26_CR27","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1471-4159.1992.tb09439.x","volume":"59","author":"SJ Kish","year":"1992","unstructured":"Kish SJ, Bergeron C, Rajput A et al (1992) Brain cytochrome oxidase in Alzheimer\u2019s disease. J Neurochem 59:776\u2013779","journal-title":"J Neurochem"},{"key":"26_CR28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0197-4580(03)00033-2","volume":"25","author":"SM Cardoso","year":"2004","unstructured":"Cardoso SM, Proenca MT, Santos S, Santana I, Oliveira CR (2004) Cytochrome c oxidase is decreased in Alzheimer\u2019s disease platelets. Neurobiol Aging 25:105\u2013110","journal-title":"Neurobiol Aging"},{"key":"26_CR29","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1212\/WNL.44.6.1086","volume":"44","author":"WD Parker Jr","year":"1994","unstructured":"Parker WD Jr, Mahr NJ, Filley CM et al (1994) Reduced platelet cytochrome c oxidase activity in Alzheimer\u2019s disease. Neurology 44:1086\u20131090","journal-title":"Neurology"},{"key":"26_CR30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.mito.2006.10.004","volume":"6","author":"J Valla","year":"2006","unstructured":"Valla J, Schneider L, Niedzielko T et al (2006) Impaired platelet mitochondrial activity in Alzheimer\u2019s disease and mild cognitive impairment. Mitochondrion 6:323\u2013330","journal-title":"Mitochondrion"},{"key":"26_CR31","doi-asserted-by":"crossref","first-page":"13623","DOI":"10.1016\/S0021-9258(17)36875-8","volume":"269","author":"D Gabuzda","year":"1994","unstructured":"Gabuzda D, Busciglio J, Chen LB, Matsudaira P, Yankner BA (1994) Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J Biol Chem 269:13623\u201313628","journal-title":"J Biol Chem"},{"key":"26_CR32","first-page":"190","volume":"64","author":"M Reivich","year":"1977","unstructured":"Reivich M, Kuhl D, Wolf A et al (1977) Measurement of local cerebral glucose metabolism in man with 18F-2-fluoro-2-deoxy-d-glucose. Acta Neurol Scand Suppl 64:190\u2013191","journal-title":"Acta Neurol Scand Suppl"},{"key":"26_CR33","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1471-4159.1977.tb10649.x","volume":"28","author":"L Sokoloff","year":"1977","unstructured":"Sokoloff L, Reivich M, Kennedy C et al (1977) The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28:897\u2013916","journal-title":"J Neurochem"},{"key":"26_CR34","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.neuroimage.2003.07.002","volume":"20","author":"AB Rocher","year":"2003","unstructured":"Rocher AB, Chapon F, Blaizot X, Baron JC, Chavoix C (2003) Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons. Neuroimage. 20:1894\u20131898","journal-title":"Neuroimage."},{"key":"26_CR35","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0166-2236(02)02264-6","volume":"25","author":"D Attwell","year":"2002","unstructured":"Attwell D, Iadecola C (2002) The neural basis of functional brain imaging signals. Trends Neurosci 25:621\u2013625","journal-title":"Trends Neurosci"},{"key":"26_CR36","first-page":"493","volume-title":"Positron emission tomography & autoradiography: principles & applications for the brain & heart","author":"JC Mazziotta","year":"1986","unstructured":"Mazziotta JC, Phelps ME (1986) Positron emission tomography studies of the brain. In: Phelps ME, Mazziotta JC, Schelbert H (eds) Positron emission tomography & autoradiography: principles & applications for the brain & heart. Raven Press, New York, pp 493\u2013579"},{"key":"26_CR37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ana.410060502","volume":"6","author":"ME Phelps","year":"1979","unstructured":"Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE (1979) Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-d-glucose: validation of method. Ann Neurol. 6:371\u2013388","journal-title":"Ann Neurol."},{"issue":"Suppl","key":"26_CR38","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/ana.410150703","volume":"15","author":"L Sokoloff","year":"1984","unstructured":"Sokoloff L (1984) Modeling metabolic processes in the brain in vivo. Ann Neurol. 15(Suppl):S1\u2013S11","journal-title":"Ann Neurol."},{"key":"26_CR39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/jcbfm.1985.23","volume":"5","author":"A Gjedde","year":"1985","unstructured":"Gjedde A, Wienhard K, Heiss WD et al (1985) Comparative regional analysis of 2-fluorodeoxyglucose and methylglucose uptake in brain of four stroke patients. With special reference to the regional estimation of the lumped constant. J Cereb Blood Flow Metab 5:163\u2013178","journal-title":"J Cereb Blood Flow Metab"},{"key":"26_CR40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/jcbfm.1985.15","volume":"5","author":"K Wienhard","year":"1985","unstructured":"Wienhard K, Pawlik G, Herholz K, Wagner R, Heiss WD (1985) Estimation of local cerebral glucose utilization by positron emission tomography of [18F]2-fluoro-2-deoxy-d-glucose: a critical appraisal of optimization procedures. J Cereb Blood Flow Metab 5:115\u2013125","journal-title":"J Cereb Blood Flow Metab"},{"key":"26_CR41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/jcbfm.1984.5","volume":"4","author":"GD Hutchins","year":"1984","unstructured":"Hutchins GD, Holden JE, Koeppe RA, Halama JR, Gatley SJ, Nickles RJ (1984) Alternative approach to single-scan estimation of cerebral glucose metabolic rate using glucose analogs, with particular application to ischemia. J Cereb Blood Flow Metab 4:35\u201340","journal-title":"J Cereb Blood Flow Metab"},{"key":"26_CR42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/jcbfm.1987.39","volume":"7","author":"AA Lammertsma","year":"1987","unstructured":"Lammertsma AA, Brooks DJ, Frackowiak RS et al (1987) Measurement of glucose utilisation with [18F]2-fluoro-2-deoxy-d-glucose: a comparison of different analytical methods. J Cereb Blood Flow Metab 7:161\u2013172","journal-title":"J Cereb Blood Flow Metab"},{"key":"26_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jcbfm.1983.1","volume":"3","author":"CS Patlak","year":"1983","unstructured":"Patlak CS, Blasberg RG, Fenstermacher JD (1983) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 3:1\u20137","journal-title":"J Cereb Blood Flow Metab"},{"key":"26_CR44","first-page":"1603","volume":"29","author":"G DiChiro","year":"1988","unstructured":"DiChiro G, Brooks RA (1988) PET quantitation: blessing and curse. J Nucl Med 29:1603\u20131604","journal-title":"J Nucl Med"},{"key":"26_CR45","first-page":"394","volume":"37","author":"KC Schmidt","year":"1996","unstructured":"Schmidt KC, Lucignani G, Sokoloff L (1996) Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination. J Nucl Med 37:394\u2013399","journal-title":"J Nucl Med"},{"key":"26_CR46","first-page":"1625","volume":"46","author":"A Drzezga","year":"2005","unstructured":"Drzezga A, Grimmer T, Riemenschneider M et al (2005) Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET. J Nucl Med 46:1625\u20131632","journal-title":"J Nucl Med"},{"key":"26_CR47","first-page":"548","volume":"42","author":"K Ishii","year":"2001","unstructured":"Ishii K, Willoch F, Minoshima S et al (2001) Statistical brain mapping of 18F-FDG PET in Alzheimer\u2019s disease: validation of anatomic standardization for atrophied brains. J Nucl Med 42:548\u2013557","journal-title":"J Nucl Med"},{"key":"26_CR48","first-page":"1238","volume":"36","author":"S Minoshima","year":"1995","unstructured":"Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE (1995) A diagnostic approach in Alzheimer\u2019s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 36:1238\u20131248","journal-title":"J Nucl Med"},{"key":"26_CR49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","volume":"42","author":"S Minoshima","year":"1997","unstructured":"Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE (1997) Metabolic reduction in the posterior cingulate cortex in very early Alzheimer\u2019s disease. Ann Neurol 42:85\u201394","journal-title":"Ann Neurol"},{"key":"26_CR50","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2967\/jnumed.107.045385","volume":"49","author":"L Mosconi","year":"2008","unstructured":"Mosconi L, Tsui WH, Herholz K et al (2008) Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer\u2019s disease, and other dementias. J Nucl Med 49:390\u2013398","journal-title":"J Nucl Med"},{"key":"26_CR51","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/nimg.2002.1208","volume":"17","author":"K Herholz","year":"2002","unstructured":"Herholz K, Salmon E, Perani D et al (2002) Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage. 17:302\u2013316","journal-title":"Neuroimage."},{"key":"26_CR52","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2967\/jnumed.111.094946","volume":"53","author":"A Caroli","year":"2012","unstructured":"Caroli A, Prestia A, Chen K et al (2012) Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: head-to-head comparison. J Nucl Med 53:592\u2013600","journal-title":"J Nucl Med"},{"key":"26_CR53","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1212\/WNL.0b013e3182872830","volume":"80","author":"A Prestia","year":"2013","unstructured":"Prestia A, Caroli A, van der Flier WM et al (2013) Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease. Neurology. 80:1048\u20131056","journal-title":"Neurology."},{"key":"26_CR54","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1001\/archneur.62.11.1728","volume":"62","author":"D Anchisi","year":"2005","unstructured":"Anchisi D, Borroni B, Franceschi M et al (2005) Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch Neurol 62:1728\u20131733","journal-title":"Arch Neurol"},{"key":"26_CR55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/nimg.1998.0381","volume":"9","author":"M Signorini","year":"1999","unstructured":"Signorini M, Paulesu E, Friston K et al (1999) Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping. Neuroimage. 9:63\u201380","journal-title":"Neuroimage."},{"key":"26_CR56","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/mds.23291","volume":"25","author":"LK Teune","year":"2010","unstructured":"Teune LK, Bartels AL, de Jong BM et al (2010) Typical cerebral metabolic patterns in neurodegenerative brain diseases. Mov Disord 25:2395\u20132404","journal-title":"Mov Disord"},{"key":"26_CR57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuroimage.2008.07.015","volume":"44","author":"I Yakushev","year":"2009","unstructured":"Yakushev I, Hammers A, Fellgiebel A et al (2009) SPM-based count normalization provides excellent discrimination of mild Alzheimer\u2019s disease and amnestic mild cognitive impairment from healthy aging. Neuroimage. 44:43\u201350","journal-title":"Neuroimage."},{"key":"26_CR58","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00500975","volume":"90","author":"A Wree","year":"1988","unstructured":"Wree A, Schleicher A (1988) The determination of the local cerebral glucose utilization with the 2-deoxyglucose method. Histochemistry 90:109\u2013121","journal-title":"Histochemistry"},{"key":"26_CR59","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1471-4159.1983.tb08086.x","volume":"40","author":"RA Hawkins","year":"1983","unstructured":"Hawkins RA, Mans AM, Davis DW, Hibbard LS, Lu DM (1983) Glucose availability to individual cerebral structures is correlated to glucose metabolism. J Neurochem 40:1013\u20131018","journal-title":"J Neurochem"},{"key":"26_CR60","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0006-8993(83)90367-0","volume":"272","author":"C Iadecola","year":"1983","unstructured":"Iadecola C, Nakai M, Mraovitch S, Ruggiero DA, Tucker LW, Reis DJ (1983) Global increase in cerebral metabolism and blood flow produced by focal electrical stimulation of dorsal medullary reticular formation in rat. Brain Res 272:101\u2013114","journal-title":"Brain Res"},{"key":"26_CR61","first-page":"391","volume":"23","author":"JC Baron","year":"1982","unstructured":"Baron JC, Lebrun-Grandie P, Collard P, Crouzel C, Mestelan G, Bousser MG (1982) Noninvasive measurement of blood flow, oxygen consumption, and glucose utilization in the same brain regions in man by positron emission tomography: concise communication. J Nucl Med 23:391\u2013399","journal-title":"J Nucl Med"},{"key":"26_CR62","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/archneur.1976.00500080001001","volume":"33","author":"ME Raichle","year":"1976","unstructured":"Raichle ME, Grubb RL Jr, Gado MH, Eichling JO, Ter-Pogossian MM (1976) Correlation between regional cerebral blood flow and oxidative metabolism. In vivo studies in man. Arch Neurol 33:523\u2013526","journal-title":"Arch Neurol"},{"key":"26_CR63","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1212\/WNL.42.4.765","volume":"42","author":"WJ Powers","year":"1992","unstructured":"Powers WJ, Perlmutter JS, Videen TO et al (1992) Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer\u2019s disease. Neurology. 42:765\u2013770","journal-title":"Neurology."},{"key":"26_CR64","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1126\/science.3260686","volume":"241","author":"PT Fox","year":"1988","unstructured":"Fox PT, Raichle ME, Mintun MA, Dence C (1988) Nonoxidative glucose consumption during focal physiologic neural activity. Science 241:462\u2013464","journal-title":"Science"},{"key":"26_CR65","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.6729458","volume":"224","author":"CA Sandman","year":"1984","unstructured":"Sandman CA, O\u2019Halloran JP, Isenhart R (1984) Is there an evoked vascular response? Science 224:1355\u20131357","journal-title":"Science"},{"key":"26_CR66","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1073\/pnas.83.4.1140","volume":"83","author":"PT Fox","year":"1986","unstructured":"Fox PT, Raichle ME (1986) Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc Natl Acad Sci USA 83:1140\u20131144","journal-title":"Proc Natl Acad Sci USA"},{"key":"26_CR67","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1073\/pnas.80.13.4179","volume":"80","author":"P Yarowsky","year":"1983","unstructured":"Yarowsky P, Kadekaro M, Sokoloff L (1983) Frequency-dependent activation of glucose utilization in the superior cervical ganglion by electrical stimulation of cervical sympathetic trunk. Proc Natl Acad Sci USA 80:4179\u20134183","journal-title":"Proc Natl Acad Sci USA"},{"key":"26_CR68","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1073\/pnas.84.15.5492","volume":"84","author":"M Kadekaro","year":"1987","unstructured":"Kadekaro M, Vance WH, Terrell ML, Gary H Jr, Eisenberg HM, Sokoloff L (1987) Effects of antidromic stimulation of the ventral root on glucose utilization in the ventral horn of the spinal cord in the rat. Proc Natl Acad Sci USA 84:5492\u20135495","journal-title":"Proc Natl Acad Sci USA"},{"key":"26_CR69","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1523\/JNEUROSCI.11-03-00641.1991","volume":"11","author":"S Zeki","year":"1991","unstructured":"Zeki S, Watson JD, Lueck CJ, Friston KJ, Kennard C, Frackowiak RS (1991) A direct demonstration of functional specialization in human visual cortex. J Neurosci 11:641\u2013649","journal-title":"J Neurosci"},{"key":"26_CR70","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/331585a0","volume":"331","author":"SE Petersen","year":"1988","unstructured":"Petersen SE, Fox PT, Posner MI, Mintun M, Raichle ME (1988) Positron emission tomographic studies of the cortical anatomy of single-word processing. Nature 331:585\u2013589","journal-title":"Nature"},{"key":"26_CR71","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ana.410220408","volume":"22","author":"HT Chugani","year":"1987","unstructured":"Chugani HT, Phelps ME, Mazziotta JC (1987) Positron emission tomography study of human brain functional development. Ann Neurol. 22:487\u2013497","journal-title":"Ann Neurol."},{"key":"26_CR72","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1126\/science.2860723","volume":"228","author":"ME Phelps","year":"1985","unstructured":"Phelps ME, Mazziotta JC (1985) Positron emission tomography: human brain function and biochemistry. Science 228:799\u2013809","journal-title":"Science"},{"key":"26_CR73","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.arr.2005.02.003","volume":"4","author":"D Schubert","year":"2005","unstructured":"Schubert D (2005) Glucose metabolism and Alzheimer\u2019s disease. Ageing Res Rev. 4:240\u2013257","journal-title":"Ageing Res Rev."},{"key":"26_CR74","first-page":"177","volume":"14","author":"PJ Magistretti","year":"1999","unstructured":"Magistretti PJ, Pellerin L (1999) Astrocytes couple synaptic activity to glucose utilization in the brain. News Physiol Sci 14:177\u2013182","journal-title":"News Physiol Sci"},{"key":"26_CR75","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-005-1762-7","volume":"32","author":"L Mosconi","year":"2005","unstructured":"Mosconi L (2005) Brain glucose metabolism in the early and specific diagnosis of Alzheimer\u2019s disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 32:486\u2013510","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"26_CR76","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.286.17.2120","volume":"286","author":"DH Silverman","year":"2001","unstructured":"Silverman DH, Small GW, Chang CY et al (2001) Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA 286:2120\u20132127","journal-title":"JAMA"},{"key":"26_CR77","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1586\/ern.10.136","volume":"10","author":"K Herholz","year":"2010","unstructured":"Herholz K (2010) Cerebral glucose metabolism in preclinical and prodromal Alzheimer\u2019s disease. Expert Rev Neurother 10:1667\u20131673","journal-title":"Expert Rev Neurother"},{"key":"26_CR78","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1007\/s00415-006-0498-z","volume":"254","author":"A Caroli","year":"2007","unstructured":"Caroli A, Testa C, Geroldi C et al (2007) Brain perfusion correlates of medial temporal lobe atrophy and white matter hyperintensities in mild cognitive impairment. J Neurol 254:1000\u20131008","journal-title":"J Neurol"},{"key":"26_CR79","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.191044198","volume":"98","author":"MJ Leon de","year":"2001","unstructured":"de Leon MJ, Convit A, Wolf OT et al (2001) Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-d-glucose\/poitron-emission tomography (FDG\/PET). Proc Natl Acad Sci USA 98:10966\u201310971","journal-title":"Proc Natl Acad Sci USA"},{"key":"26_CR80","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.neurobiolaging.2006.12.008","volume":"29","author":"L Mosconi","year":"2008","unstructured":"Mosconi L, De Santi S, Li J et al (2008) Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiol Aging 29:676\u2013692","journal-title":"Neurobiol Aging"},{"key":"26_CR81","doi-asserted-by":"crossref","unstructured":"Mosconi L, Tsui W, Murray J et al (2012) Maternal age affects brain metabolism in adult children of mothers affected by Alzheimer\u2019s disease. Neurobiol Aging 33:624. e1\u2013e9","DOI":"10.1016\/j.neurobiolaging.2011.03.003"},{"key":"26_CR82","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neuroimage.2006.09.022","volume":"34","author":"FT Sun","year":"2007","unstructured":"Sun FT, Schriber RA, Greenia JM, He J, Gitcho A, Jagust WJ (2007) Automated template-based PET region of interest analyses in the aging brain. Neuroimage 34:608\u2013617","journal-title":"Neuroimage"},{"key":"26_CR83","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00259-005-1956-z","volume":"33","author":"L Mosconi","year":"2006","unstructured":"Mosconi L, De Santi S, Li Y et al (2006) Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer\u2019s disease using FDG-PET. Eur J Nucl Med Mol Imaging. 33:210\u2013221","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"26_CR84","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/brain\/awr066","volume":"134","author":"A Drzezga","year":"2011","unstructured":"Drzezga A, Becker JA, Van Dijk KR et al (2011) Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden. Brain. 134:1635\u20131646","journal-title":"Brain."},{"key":"26_CR85","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/brain\/122.8.1519","volume":"122","author":"K Meguro","year":"1999","unstructured":"Meguro K, Blaizot X, Kondoh Y, Le Mestric C, Baron JC, Chavoix C (1999) Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer\u2019s disease. Brain. 122:1519\u20131531","journal-title":"Brain."},{"key":"26_CR86","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1523\/JNEUROSCI.1392-08.2008","volume":"28","author":"N Villain","year":"2008","unstructured":"Villain N, Desgranges B, Viader F et al (2008) Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer\u2019s disease. J Neurosci 28:6174\u20136181","journal-title":"J Neurosci"},{"key":"26_CR87","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00259-009-1218-6","volume":"37","author":"S Morbelli","year":"2010","unstructured":"Morbelli S, Piccardo A, Villavecchia G et al (2010) Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study. Eur J Nucl Med Mol Imaging 37:36\u201345","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"26_CR88","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1212\/01.WNL.0000163856.13524.08","volume":"64","author":"L Mosconi","year":"2005","unstructured":"Mosconi L, Tsui WH, De Santi S et al (2005) Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology 64:1860\u20131867","journal-title":"Neurology"},{"key":"26_CR89","first-page":"1141","volume":"36","author":"A Loessner","year":"1995","unstructured":"Loessner A, Alavi A, Lewandrowski KU, Mozley D, Souder E, Gur RE (1995) Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. J Nucl Med 36:1141\u20131149","journal-title":"J Nucl Med"},{"key":"26_CR90","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00004647-199605000-00005","volume":"16","author":"JR Moeller","year":"1996","unstructured":"Moeller JR, Ishikawa T, Dhawan V et al (1996) The metabolic topography of normal aging. J Cereb Blood Flow Metab 16:385\u2013398","journal-title":"J Cereb Blood Flow Metab"},{"key":"26_CR91","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF02238755","volume":"66","author":"S Santi De","year":"1995","unstructured":"De Santi S, de Leon MJ, Convit A et al (1995) Age-related changes in brain: II. Positron emission tomography of frontal and temporal lobe glucose metabolism in normal subjects. Psychiatr Q 66:357\u2013370","journal-title":"Psychiatr Q"},{"key":"26_CR92","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neurobiolaging.2007.05.019","volume":"30","author":"G Kalpouzos","year":"2009","unstructured":"Kalpouzos G, Chetelat G, Baron JC et al (2009) Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging. Neurobiol Aging 30:112\u2013124","journal-title":"Neurobiol Aging"},{"key":"26_CR93","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0197-4580(02)00036-2","volume":"23","author":"JP Blass","year":"2002","unstructured":"Blass JP (2002) Alzheimer\u2019s disease and Alzheimer\u2019s dementia: distinct but overlapping entities. Neurobiol Aging 23:1077\u20131084","journal-title":"Neurobiol Aging"},{"key":"26_CR94","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1212\/WNL.36.10.1390","volume":"36","author":"CL Grady","year":"1986","unstructured":"Grady CL, Haxby JV, Schlageter NL, Berg G, Rapoport SI (1986) Stability of metabolic and neuropsychological asymmetries in dementia of the Alzheimer type. Neurology 36:1390\u20131392","journal-title":"Neurology"},{"key":"26_CR95","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.1990.00530070043010","volume":"47","author":"JV Haxby","year":"1990","unstructured":"Haxby JV, Grady CL, Koss E et al (1990) Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch Neurol 47:753\u2013760","journal-title":"Arch Neurol"},{"key":"26_CR96","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/brain\/awp132","volume":"132","author":"M Fouquet","year":"2009","unstructured":"Fouquet M, Desgranges B, Landeau B et al (2009) Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer\u2019s disease. Brain 132:2058\u20132067","journal-title":"Brain"},{"key":"26_CR97","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/archneur.64.7.1015","volume":"64","author":"GA Marshall","year":"2007","unstructured":"Marshall GA, Monserratt L, Harwood D, Mandelkern M, Cummings JL, Sultzer DL (2007) Positron emission tomography metabolic correlates of apathy in Alzheimer disease. Arch Neurol 64:1015\u20131020","journal-title":"Arch Neurol"},{"key":"26_CR98","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/archneur.65.5.650","volume":"65","author":"B Kuczynski","year":"2008","unstructured":"Kuczynski B, Reed B, Mungas D, Weiner M, Chui HC, Jagust W (2008) Cognitive and anatomic contributions of metabolic decline in Alzheimer disease and cerebrovascular disease. Arch Neurol 65:650\u2013655","journal-title":"Arch Neurol"},{"key":"26_CR99","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/gps.2452","volume":"25","author":"BK Woo","year":"2010","unstructured":"Woo BK, Harwood DG, Melrose RJ et al (2010) Executive deficits and regional brain metabolism in Alzheimer\u2019s disease. Int J Geriatr Psychiatry 25:1150\u20131158","journal-title":"Int J Geriatr Psychiatry"},{"key":"26_CR100","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archneurol.2009.266","volume":"66","author":"RC Petersen","year":"2009","unstructured":"Petersen RC, Roberts RO, Knopman DS et al (2009) Mild cognitive impairment: ten years later. Arch Neurol 66:1447\u20131455","journal-title":"Arch Neurol"},{"key":"26_CR101","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ana.20799","volume":"59","author":"W Jagust","year":"2006","unstructured":"Jagust W, Gitcho A, Sun F, Kuczynski B, Mungas D, Haan M (2006) Brain imaging evidence of preclinical Alzheimer\u2019s disease in normal aging. Ann Neurol 59:673\u2013681","journal-title":"Ann Neurol"},{"key":"26_CR102","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00259-008-1039-z","volume":"36","author":"L Mosconi","year":"2009","unstructured":"Mosconi L, Mistur R, Switalski R et al (2009) FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging 36:811\u2013822","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"26_CR103","first-page":"1778","volume":"47","author":"L Mosconi","year":"2006","unstructured":"Mosconi L, Sorbi S, de Leon MJ et al (2006) Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer\u2019s disease. J Nucl Med 47:1778\u20131786","journal-title":"J Nucl Med"},{"key":"26_CR104","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3233\/JAD-2009-1091","volume":"17","author":"F Nobili","year":"2009","unstructured":"Nobili F, De Carli F, Frisoni GB et al (2009) SPECT predictors of cognitive decline and Alzheimer\u2019s disease in mild cognitive impairment. J Alzheimers Dis 17:761\u2013772","journal-title":"J Alzheimers Dis"},{"key":"26_CR105","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1212\/01.WNL.0000055847.17752.E6","volume":"60","author":"G Chetelat","year":"2003","unstructured":"Chetelat G, Desgranges B, de la Sayette V, Viader F, Eustache F, Baron JC (2003) Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer\u2019s disease? Neurology. 60:1374\u20131377","journal-title":"Neurology."},{"key":"26_CR106","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s00259-003-1194-1","volume":"30","author":"A Drzezga","year":"2003","unstructured":"Drzezga A, Lautenschlager N, Siebner H et al (2003) Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer\u2019s disease: a PET follow-up study. Eur J Nucl Med Mol Imaging 30:1104\u20131113","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"26_CR107","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1523\/JNEUROSCI.21-13-04923.2001","volume":"21","author":"J Valla","year":"2001","unstructured":"Valla J, Berndt JD, Gonzalez-Lima F (2001) Energy hypometabolism in posterior cingulate cortex of Alzheimer\u2019s patients: superficial laminar cytochrome oxidase associated with disease duration. J Neurosci 21:4923\u20134930","journal-title":"J Neurosci"},{"key":"26_CR108","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1073\/pnas.0709259105","volume":"105","author":"WS Liang","year":"2008","unstructured":"Liang WS, Reiman EM, Valla J et al (2008) Alzheimer\u2019s disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc Natl Acad Sci USA 105:4441\u20134446","journal-title":"Proc Natl Acad Sci USA"},{"key":"26_CR109","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1073\/pnas.061509598","volume":"98","author":"EM Reiman","year":"2001","unstructured":"Reiman EM, Caselli RJ, Chen K, Alexander GE, Bandy D, Frost J (2001) Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer\u2019s disease. Proc Natl Acad Sci USA 98:3334\u20133339","journal-title":"Proc Natl Acad Sci USA"},{"key":"26_CR110","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1073\/pnas.2635903100","volume":"101","author":"EM Reiman","year":"2004","unstructured":"Reiman EM, Chen K, Alexander GE et al (2004) Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer\u2019s dementia. Proc Natl Acad Sci USA 101:284\u2013289","journal-title":"Proc Natl Acad Sci USA"},{"key":"26_CR111","doi-asserted-by":"crossref","first-page":"8299","DOI":"10.1073\/pnas.0500579102","volume":"102","author":"EM Reiman","year":"2005","unstructured":"Reiman EM, Chen K, Alexander GE et al (2005) Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proc Natl Acad Sci USA 102:8299\u20138302","journal-title":"Proc Natl Acad Sci USA"},{"key":"26_CR112","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ana.410250511","volume":"25","author":"LA Farrer","year":"1989","unstructured":"Farrer LA, O\u2019Sullivan DM, Cupples LA, Growdon JH, Myers RH (1989) Assessment of genetic risk for Alzheimer\u2019s disease among first-degree relatives. Ann Neurol 25:485\u2013493","journal-title":"Ann Neurol"},{"key":"26_CR113","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/jama.287.3.329","volume":"287","author":"RC Green","year":"2002","unstructured":"Green RC, Cupples LA, Go R et al (2002) Risk of dementia among white and African American relatives of patients with Alzheimer disease. JAMA 287:329\u2013336","journal-title":"JAMA"},{"key":"26_CR114","doi-asserted-by":"crossref","first-page":"19067","DOI":"10.1073\/pnas.0705036104","volume":"104","author":"L Mosconi","year":"2007","unstructured":"Mosconi L, Brys M, Switalski R et al (2007) Maternal family history of Alzheimer\u2019s disease predisposes to reduced brain glucose metabolism. Proc Natl Acad Sci USA 104:19067\u201319072","journal-title":"Proc Natl Acad Sci USA"},{"key":"26_CR115","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1212\/01.wnl.0000333247.51383.43","volume":"72","author":"L Mosconi","year":"2009","unstructured":"Mosconi L, Mistur R, Switalski R et al (2009) Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease. Neurology 72:513\u2013520","journal-title":"Neurology"},{"key":"26_CR116","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1017\/S0967199405003382","volume":"13","author":"M Wilding","year":"2005","unstructured":"Wilding M, Di Matteo L, Dale B (2005) The maternal age effect: a hypothesis based on oxidative phosphorylation. Zygote 13:317\u2013323","journal-title":"Zygote"},{"key":"26_CR117","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, Cupples LA, Haines JL et al (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278:1349\u20131356","journal-title":"JAMA"},{"key":"26_CR118","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3233\/JAD-2011-110866","volume":"27","author":"L Mosconi","year":"2011","unstructured":"Mosconi L, de Leon M, Murray J et al (2011) Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer\u2019s disease. J Alzheimers Dis 27:483\u2013490","journal-title":"J Alzheimers Dis"},{"key":"26_CR119","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.biopsych.2010.07.011","volume":"68","author":"L Mosconi","year":"2010","unstructured":"Mosconi L, Glodzik L, Mistur R et al (2010) Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer\u2019s. Biol Psychiatry 68:913\u2013921","journal-title":"Biol Psychiatry"},{"key":"26_CR120","doi-asserted-by":"crossref","unstructured":"Berti V, Mosconi L, Glodzik L et al (2011) Structural brain changes in normal individuals with a maternal history of Alzheimer\u2019s. Neurobiol Aging. 32:2325.e17-26","DOI":"10.1016\/j.neurobiolaging.2011.01.001"},{"key":"26_CR121","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1212\/WNL.0b013e31820e7b74","volume":"76","author":"RA Honea","year":"2011","unstructured":"Honea RA, Swerdlow RH, Vidoni ED, Burns JM (2011) Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease. Neurology 76:822\u2013829","journal-title":"Neurology"},{"key":"26_CR122","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1212\/WNL.0b013e3181c918cb","volume":"74","author":"RA Honea","year":"2010","unstructured":"Honea RA, Swerdlow RH, Vidoni ED, Goodwin J, Burns JM (2010) Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease. Neurology 74:113\u2013120","journal-title":"Neurology"},{"key":"26_CR123","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.neurobiolaging.2010.07.020","volume":"33","author":"JP Andrawis","year":"2012","unstructured":"Andrawis JP, Hwang KS, Green AE et al (2012) Effects of ApoE4 and maternal history of dementia on hippocampal atrophy. Neurobiol Aging 33:856\u2013866","journal-title":"Neurobiol Aging"},{"key":"26_CR124","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE, Engler H, Nordberg A et al (2004) Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B. Ann Neurol 55:306\u2013319","journal-title":"Ann Neurol"},{"key":"26_CR125","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1073\/pnas.0914141107","volume":"107","author":"L Mosconi","year":"2010","unstructured":"Mosconi L, Rinne JO, Tsui WH et al (2010) Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer\u2019s. Proc Natl Acad Sci USA 107:5949\u20135954","journal-title":"Proc Natl Acad Sci USA"},{"key":"26_CR126","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neurobiolaging.2012.03.002","volume":"34","author":"L Mosconi","year":"2013","unstructured":"Mosconi L, Rinne JO, Tsui WH et al (2013) Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer\u2019s parents. Neurobiol Aging 34:22\u201334","journal-title":"Neurobiol Aging"},{"key":"26_CR127","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3233\/JAD-121867","volume":"35","author":"L Mosconi","year":"2013","unstructured":"Mosconi L, Andrews R, Matthews DC (2013) Comparing brain amyloid deposition, glucose metabolism and atrophy in mild cognitive impairment with and without a family history of dementia. J Alzheimer\u2019s Dis 35:509\u2013524","journal-title":"J Alzheimer\u2019s Dis"}],"container-title":["Clinical and Translational Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40336-013-0026-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40336-013-0026-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40336-013-0026-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T20:55:57Z","timestamp":1645995357000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40336-013-0026-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,10]]},"references-count":127,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["26"],"URL":"https:\/\/doi.org\/10.1007\/s40336-013-0026-y","relation":{},"ISSN":["2281-5872","2281-7565"],"issn-type":[{"value":"2281-5872","type":"print"},{"value":"2281-7565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,10]]}}}